Logo image of BALY

BALLY'S CORP (BALY) Stock Fundamental Analysis

USA - NYSE:BALY - US05875B3042 - Common Stock

13.7 USD
+0.94 (+7.37%)
Last: 10/15/2025, 8:15:18 PM
13.65 USD
-0.05 (-0.36%)
After Hours: 10/15/2025, 8:15:18 PM
Fundamental Rating

2

Taking everything into account, BALY scores 2 out of 10 in our fundamental rating. BALY was compared to 135 industry peers in the Hotels, Restaurants & Leisure industry. Both the profitability and financial health of BALY have multiple concerns. While showing a medium growth rate, BALY is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

BALY had negative earnings in the past year.
BALY had a positive operating cash flow in the past year.
BALY had negative earnings in each of the past 5 years.
In the past 5 years BALY always reported a positive cash flow from operatings.
BALY Yearly Net Income VS EBIT VS OCF VS FCFBALY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

With a Return On Assets value of -7.42%, BALY is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
BALY's Return On Equity of -91.83% is on the low side compared to the rest of the industry. BALY is outperformed by 66.67% of its industry peers.
BALY has a worse Return On Invested Capital (0.57%) than 75.56% of its industry peers.
Industry RankSector Rank
ROA -7.42%
ROE -91.83%
ROIC 0.57%
ROA(3y)-6.39%
ROA(5y)-4.24%
ROE(3y)-639.86%
ROE(5y)-385.68%
ROIC(3y)N/A
ROIC(5y)N/A
BALY Yearly ROA, ROE, ROICBALY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

1.3 Margins

With a Operating Margin value of 1.99%, BALY is not doing good in the industry: 73.33% of the companies in the same industry are doing better.
BALY has a Gross Margin of 54.78%. This is in the better half of the industry: BALY outperforms 65.93% of its industry peers.
BALY's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.99%
PM (TTM) N/A
GM 54.78%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.11%
GM growth 5Y-3.47%
BALY Yearly Profit, Operating, Gross MarginsBALY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

0

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BALY is destroying value.
Compared to 1 year ago, BALY has more shares outstanding
The number of shares outstanding for BALY has been increased compared to 5 years ago.
The debt/assets ratio for BALY is higher compared to a year ago.
BALY Yearly Shares OutstandingBALY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
BALY Yearly Total Debt VS Total AssetsBALY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

BALY has an Altman-Z score of 0.28. This is a bad value and indicates that BALY is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.28, BALY is doing worse than 82.22% of the companies in the same industry.
A Debt/Equity ratio of 5.65 is on the high side and indicates that BALY has dependencies on debt financing.
BALY has a Debt to Equity ratio of 5.65. This is in the lower half of the industry: BALY underperforms 61.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.65
Debt/FCF N/A
Altman-Z 0.28
ROIC/WACC0.07
WACC8.49%
BALY Yearly LT Debt VS Equity VS FCFBALY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 0.49 indicates that BALY may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.49, BALY is doing worse than 75.56% of the companies in the same industry.
BALY has a Quick Ratio of 0.49. This is a bad value and indicates that BALY is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of BALY (0.47) is worse than 73.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.49
Quick Ratio 0.47
BALY Yearly Current Assets VS Current LiabilitesBALY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

4

3. Growth

3.1 Past

BALY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -33.90%.
The Revenue has decreased by -1.10% in the past year.
BALY shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 36.16% yearly.
EPS 1Y (TTM)-33.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-203.23%
Revenue 1Y (TTM)-1.1%
Revenue growth 3Y22.83%
Revenue growth 5Y36.16%
Sales Q2Q%5.77%

3.2 Future

Based on estimates for the next years, BALY will show a very strong growth in Earnings Per Share. The EPS will grow by 22.94% on average per year.
The Revenue is expected to grow by 6.76% on average over the next years.
EPS Next Y64.07%
EPS Next 2Y34.23%
EPS Next 3Y22.94%
EPS Next 5YN/A
Revenue Next Year3.75%
Revenue Next 2Y5.28%
Revenue Next 3Y6.76%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BALY Yearly Revenue VS EstimatesBALY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
BALY Yearly EPS VS EstimatesBALY Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -2 -4 -6 -8 -10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

BALY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BALY. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BALY Price Earnings VS Forward Price EarningsBALY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as BALY.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.91
BALY Per share dataBALY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40 -60

4.3 Compensation for Growth

BALY's earnings are expected to grow with 22.94% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.23%
EPS Next 3Y22.94%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BALY!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BALLY'S CORP

NYSE:BALY (10/15/2025, 8:15:18 PM)

After market: 13.65 -0.05 (-0.36%)

13.7

+0.94 (+7.37%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)08-11 2025-08-11/amc
Earnings (Next)11-04 2025-11-04/bmo
Inst Owners75.35%
Inst Owner Change0%
Ins Owners12.56%
Ins Owner Change0.42%
Market Cap672.94M
Analysts50.91
Price Target12.7 (-7.3%)
Short Float %0.73%
Short Ratio3.3
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-712.79%
Min EPS beat(2)-1443.99%
Max EPS beat(2)18.41%
EPS beat(4)1
Avg EPS beat(4)-1094.62%
Min EPS beat(4)-2765.33%
Max EPS beat(4)18.41%
EPS beat(8)2
Avg EPS beat(8)-779.41%
EPS beat(12)2
Avg EPS beat(12)-863.1%
EPS beat(16)4
Avg EPS beat(16)-655.13%
Revenue beat(2)0
Avg Revenue beat(2)-2.3%
Min Revenue beat(2)-4.31%
Max Revenue beat(2)-0.29%
Revenue beat(4)0
Avg Revenue beat(4)-3.46%
Min Revenue beat(4)-5.87%
Max Revenue beat(4)-0.29%
Revenue beat(8)0
Avg Revenue beat(8)-3.49%
Revenue beat(12)0
Avg Revenue beat(12)-2.89%
Revenue beat(16)0
Avg Revenue beat(16)-4.47%
PT rev (1m)0%
PT rev (3m)-13.84%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-110.63%
EPS NY rev (1m)-100.24%
EPS NY rev (3m)-154.08%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.07%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.39%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.27
P/FCF N/A
P/OCF 12.72
P/B 1.07
P/tB N/A
EV/EBITDA 10.91
EPS(TTM)-11.1
EYN/A
EPS(NY)-2.32
Fwd EYN/A
FCF(TTM)-4.62
FCFYN/A
OCF(TTM)1.08
OCFY7.86%
SpS50.02
BVpS12.83
TBVpS-61.71
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.42%
ROE -91.83%
ROCE 0.72%
ROIC 0.57%
ROICexc 0.58%
ROICexgc 1.3%
OM 1.99%
PM (TTM) N/A
GM 54.78%
FCFM N/A
ROA(3y)-6.39%
ROA(5y)-4.24%
ROE(3y)-639.86%
ROE(5y)-385.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.11%
GM growth 5Y-3.47%
F-Score6
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 5.65
Debt/FCF N/A
Debt/EBITDA 9.52
Cap/Depr 85.99%
Cap/Sales 11.38%
Interest Coverage 0.16
Cash Conversion 14.15%
Profit Quality N/A
Current Ratio 0.49
Quick Ratio 0.47
Altman-Z 0.28
F-Score6
WACC8.49%
ROIC/WACC0.07
Cap/Depr(3y)125.58%
Cap/Depr(5y)105.92%
Cap/Sales(3y)17.68%
Cap/Sales(5y)13.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-33.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-203.23%
EPS Next Y64.07%
EPS Next 2Y34.23%
EPS Next 3Y22.94%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.1%
Revenue growth 3Y22.83%
Revenue growth 5Y36.16%
Sales Q2Q%5.77%
Revenue Next Year3.75%
Revenue Next 2Y5.28%
Revenue Next 3Y6.76%
Revenue Next 5YN/A
EBIT growth 1Y260.61%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year376.88%
EBIT Next 3Y72.27%
EBIT Next 5YN/A
FCF growth 1Y18.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-68.67%
OCF growth 3Y11.25%
OCF growth 5Y3.91%